Get the Stockscreener App
1.34
5.63%
-0.08
After Hours:
1.35
0.01
+0.75%
Revelation Biosciences Inc stock is traded at $1.34, with a volume of 292.56K.
It is down -5.63% in the last 24 hours and down -30.21% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$1.42
Open:
$1.41
24h Volume:
292.56K
Relative Volume:
0.71
Market Cap:
$3.13M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.0721
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-6.29%
1M Performance:
-30.21%
6M Performance:
-57.86%
1Y Performance:
-89.67%
1-Day Range:
$1.275
$1.41
1-Week Range:
$1.275
$1.69
52-Week Range:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.34 | 3.32M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Revelation Biosciences Inc Stock (REVB) Latest News
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesWeekly Trade Review & Capital Efficient Trading Techniques - newser.com
Revelation Biosciences Inc. Equity Warrant stock chart pattern explainedPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Will Revelation Biosciences Inc. stock benefit from automationTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Is now a turning point for Revelation Biosciences Inc. Equity WarrantMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
Best data tools to analyze Revelation Biosciences Inc. Equity Warrant stockPortfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
Does Revelation Biosciences Inc. Equity Warrant stock trade at a discount to peers2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Will Revelation Biosciences Inc. stock remain a Wall Street favorite2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Revelation Biosciences Inc. stock trend outlook and recovery pathTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Using Python tools to backtest Revelation Biosciences Inc. Equity Warrant strategiesPortfolio Growth Summary & Real-Time Sentiment Analysis - newser.com
Will breakout in Revelation Biosciences Inc. lead to full recoveryStock Surge & Reliable Momentum Entry Alerts - newser.com
Can Revelation Biosciences Inc. Equity Warrant stock attract ESG capital inflowsWeekly Risk Summary & Entry Point Confirmation Signals - newser.com
Signal strength of Revelation Biosciences Inc. stock in tech scanners2025 Year in Review & Free High Return Stock Watch Alerts - newser.com
Is Revelation Biosciences Inc. Equity Warrant forming a bottoming baseWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Market reaction to Revelation Biosciences Inc.’s recent newsWeekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds - Newport Daily News
Live market analysis of Revelation Biosciences Inc. Equity WarrantWall Street Watch & Verified Momentum Stock Watchlist - newser.com
How Revelation Biosciences Inc. Equity Warrant stock performs in high volatility markets2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Will Revelation Biosciences Inc. Equity Warrant stock deliver long term returnsGDP Growth & Stock Portfolio Risk Control - newser.com
Will Revelation Biosciences Inc. stock recover after recent dropShare Buyback & Daily Volume Surge Trade Alerts - newser.com
Candlestick signals on Revelation Biosciences Inc. stock todayMarket Risk Report & Low Risk High Win Rate Stock Picks - newser.com
Will Revelation Biosciences Inc. Equity Warrant continue its uptrend2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Is Revelation Biosciences Inc. Equity Warrant stock ready for a breakoutJobs Report & Growth Oriented Trading Recommendations - newser.com
Sector ETF performance correlation with Revelation Biosciences Inc. Equity WarrantJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Why Revelation Biosciences Inc. Equity Warrant stock is considered a top pickAnalyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Revelation Biosciences Raises $9.6M Through Warrant Exercise - MSN
Revelation Biosciences Inc Equity Warrant Stock Analysis and ForecastStock Screening Results & Rapid Wealth Building Tips - earlytimes.in
Long term hold vs stop loss in Revelation Biosciences Inc. Equity WarrantSwing Trade & Free Reliable Trade Execution Plans - newser.com
What to expect from Revelation Biosciences Inc. Equity Warrant in the next 30 days2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
Has Hipolin Limited Reached Fair Value or Is There More UpsideHealthcare Stock Analysis & Budget Friendly Trading Ideas - earlytimes.in
Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study - Pensacola News Journal
Custom strategy builders for tracking Revelation Biosciences Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - newser.com
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):